Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial

@article{Sigwart2002CoronaryAB,
  title={Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial},
  author={U. Sigwart and R. Stables and J. Booth and R. Erbel and P. W{\"a}hrborg and J. Lubsen and P. Nihoyannopoulos and J. Pepper and S. King and W. Weintraub and P. Sleight and T. Clayton and S. Pocock and F. Nugara and A. Rickards and N. Chronos and Flather and S. Thompson and P. Dooley and J. Collinson and M. Stuteville and N. Delahunty and A. Wright and M. Forster and P. Ludman and A. Souza and T. Ischinger and P. Buszman and E. Martuscelli and S. Davies and J. Goy and Z. Olivari and M. Shibata and A. Bakhai and D. P{\'e}rez and K. Kotsiva and R. Kamdar and G. Koutroulis and M. Ritsou and R. Balcon and P. Sergeant and R. Perry and C. Illsley and I. Simpson and Norell and L. Grip and J. Heikkila and C. Macaya and S. Brecker and J. Angel and Legrand and Martyn Thomas and D. Roberts and G. Bernardi and W. Wijns and L. Bilodeau and C. Buller and J. Nordrehaug and Jac da Cunha and G. Schuler and JF Marquis and W. Waas and M. Pfisterer and H. Mudra and Klauss and K. Niemela and B. Meier and K. Endresen and R. Simon and E. Eckhout and A. Manari and O. Ormerod and L. Corr and S. Gomes and {\'A}. Cequier and ML Knudtson and N. Kokott and S. Golf and GF Meloni and S. Chierchia and P. Groves and C. Vassanelli and M. Vald{\'e}s and B. Luderitz and D. Cumberland and H. Olsson and C. Vrints},
  journal={The Lancet},
  year={2002},
  volume={360},
  pages={965-970}
}
BACKGROUND Results of trials, comparing percutaneous transluminal coronary angioplasty (PTCA) with coronary artery bypass grafting (CABG), indicate that rates of death or myocardial infarction are similar with either treatment strategy. Management with PTCA is, however, associated with an increased requirement for subsequent, additional revascularisation. Coronary stents, used as an adjunct to PTCA, reduce restenosis and the need for repeat revascularisation. The aim of the Stent or Surgery… Expand

Paper Mentions

Interventional Clinical Trial
A randomised controlled trial to compare two strategies for the investigation of coronary artery disease at the time of angiography. Patients will be randomised to conventional… Expand
ConditionsAcute Coronary Syndrome, Chest Pain, Non ST Segment Elevation Acute Coronary Syndrome, (+1 more)
InterventionDevice
Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial.
TLDR
The CARDia trial did show that multivessel PCI is feasible in patients with diabetes, but longer-term follow-up and data from other trials will be needed to provide a more precise comparison of the efficacy of these 2 revascularization strategies. Expand
Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data
TLDR
CABG had a mortality benefit over PCI in patients with multivessel disease, particularly those with diabetes and higher coronary complexity, and no benefit for CABG over PCI was seen in Patients with left main disease. Expand
Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trials.
TLDR
In the modern era of stenting and optimum medical therapy, revascularisation of patients with diabetes and multivessel coronary artery disease by CABG decreases long-term mortality by about a third compared with PCI using either BMS or DES. Expand
Outcomes of Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention With Drug-Eluting Stents for Patients With Multivessel Coronary Artery Disease
TLDR
Compared with PCI with drug-eluting stents, CABG resulted in improved major adverse cardiovascular and cerebrovascular event in patients with 2- and 3-vessel coronary artery disease, primarily in those with underlying diabetes. Expand
Outcomes With Coronary Artery Bypass Graft Surgery Versus Percutaneous Coronary Intervention for Patients With Diabetes Mellitus: Can Newer Generation Drug-Eluting Stents Bridge the Gap?
TLDR
In patients with diabetes mellitus, evidence from indirect comparison shows similar mortality between CABG and PCI using cobalt–chromium everolimus-eluting stent, which needs to be tested in future trials. Expand
One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials.
TLDR
One year after the initial procedure, percutaneous coronary intervention with multiple stenting and coronary artery bypass graft surgery provided a similar degree of protection against death, myocardial infarction, or stroke for patients with multisystem disease. Expand
One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: A meta-analysis of individual patient data from randomized clinical trials
TLDR
One year after the initial procedure, percutaneous coronary intervention with multiple stenting and coronary artery bypass graft surgery provided a similar degree of protection against death, myocardial infarction, or stroke for patients with multisystem disease. Expand
Cost-Effectiveness of Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Bypass Surgery for Patients With 3-Vessel or Left Main Coronary Artery Disease: Final Results From the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial
TLDR
For most patients with 3-vessel or left main coronary artery disease, CABG is a clinically and economically attractive revascularization strategy compared with DES-PCI, however, among patients with less complex disease, DES- PCI may be preferred on both clinical and economic grounds. Expand
Randomized, Controlled Trial of Coronary Artery Bypass Surgery Versus Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease: Six-Year Follow-Up From the Stent or Surgery Trial (SoS)
TLDR
At a median follow-up of 6 years, a continuing survival advantage was observed for patients managed with CABG, which is not consistent with results from other stent-versus-CABG studies. Expand
Meta-Analysis Comparing the Risk of Myocardial Infarction Following Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention in Patients With Multivessel or Left Main Coronary Artery Disease.
TLDR
A present meta-analysis of studies involving patients with multivessel or left main CAD suggests a significant benefit of CABG over PCI concerning the risk of future MI. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 14 REFERENCES
A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. German Angioplasty Bypass Surgery Investigation (GABI)
TLDR
In selected patients with multivessel coronary disease, PTCA and CABG as initial treatments resulted in equivalent improvement in angina after one year, however, in order to achieve similar clinical outcomes, the patients treated with P TCA were more likely to require further interventions and antianginal drugs, whereas the patients treating with CABGs were morelikely to sustain an acute myocardial infarction at the time of the procedure. Expand
Argentine Randomized Study: Coronary Angioplasty with Stenting versus Coronary Bypass Surgery in patients with Multiple-Vessel Disease (ERACI II): 30-day and one-year follow-up results. ERACI II Investigators.
TLDR
In this selected high-risk group of patients with multivessel disease, PTCR with stent implantation showed better survival and freedom from MI than did conventional surgery. Expand
Argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease (ERACI): in-hospital results and 1-year follow-up. ERACI Group.
TLDR
Although at 1-year follow-up there were no differences in survival and freedom from myocardial infarction, patients in the coronary artery bypass grafting group were more frequently free from angina, reinterventions and combined events than were patients inThe coronary angioplasty group. Expand
Design of the 'Stent or Surgery' trial (SoS): a randomized controlled trial to compare coronary artery bypass grafting with percutaneous transluminal coronary angioplasty and primary stent implantation in patients with multi-vessel coronary artery disease.
  • R. Stables
  • Medicine
  • Seminars in interventional cardiology : SIIC
  • 1999
The 'Stent or Surgery' trial (SoS) is a randomized controlled trial to compare coronary artery bypass grafting with percutaneous transluminal coronary angioplasty and primary stent implantation inExpand
CORONARY ANGIOPLASTY VERSUS CORONARY-ARTERY BYPASS-SURGERY - THE RANDOMIZED INTERVENTION TREATMENT OF ANGINA (RITA) TRIAL
TLDR
It is indicated that recovery after CABG, the more invasive procedure, takes longer than after PTCA, however, C ABG leads to less risk of angina and fewer additional diagnostic and therapeutic interventions in the first 2 years than PTC a. Expand
Coronary angioplasty versus coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) trial
TLDR
It is indicated that recovery after CABG, the more invasive procedure, takes longer than after PTCA, however, C ABG leads to less risk of angina and fewer additional diagnostic and therapeutic interventions in the first 2 years than PTC a. Expand
A Randomized Trial Comparing Coronary Angioplasty with Coronary Bypass Surgery
TLDR
A three-year prospective, randomized trial comparing the outcomes of percutaneous transluminal coronary angioplasty as compared with coronary-artery bypass grafting for patients with multivessel coronary artery disease. Expand
Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease.
TLDR
It is found that in selected patients with multivessel disease suitable for treatment with either procedure, an initial strategy of PTCA does not result in a poorer five-year clinical outcome than CABG, although subsequent revascularization was required more often with this strategy. Expand
Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease.
TLDR
As measured one year after the procedure, coronary stenting for multivessel disease is less expensive than bypass surgery and offers the same degree of protection against death, stroke, and myocardial infarction, however, stenting is associated with a greater need for repeated revascularization. Expand
Chronic coronary artery disease: drugs, angioplasty, or surgery?
TLDR
A recent meta-analysis comparing angioplasty with bypass surgery is most appropriately interpreted in the context of previous trials comparing angoplasty or bypass surgery with medical treatment. Expand
...
1
2
...